Search results for: Innovation Policy Prize
Filter search results
Price Transparency: Good or Bad? What Does Literature and Theory Tell Us?
17 March 2020
…of innovation). For the R&D-based pharmaceutical industry, prices had to be above short run costs. How much above should vary according to the value delivered to a health system, which…
Costs and Benefits of Regulating New Product Development in the UK Pharmaceutical Industry
3 January 1982
…costs of pharmaceutical innovation. This study by Keith Hartley and Alan Maynard is… This is the second in an occasional series of Pharmaceutical Industry Papers to be published by OHE….
Cost and Benefits of Pharmaceutical Research
1 May 1987
…as part of a vear of celebration to mark the Silver Jubilee of OHE. The whole subject of medical innovation has been central to the development of the National Health…
Innovative Competition in Medicine
1 January 1992
…of innovation would lead from classical entrepreneurial capitalism to a form of socialism has proved wrong, his chapters on the nature of innovative competition have largely stood the test of…
New evaluation model finds widespread adoption of cell and gene therapies may unlock billions for the UK economy
20 October 2025
…of healthcare innovations, such as cell and gene therapies. It evaluates the economic gains that the large-scale adoption of advanced therapies could provide for individuals, the NHS, and the wider…
How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine? Where are we 6 Months on?
1 July 2021
…and manufacturing supply have to be an important part of the policy mix. The second reason given for push incentives is to enable countries to pre-empt supplies by requiring priority…
2025 Wrapped: Health, policy shifts & what’s next
22 January 2026, 3:00pm
Share this: In January we recapped the biggest topics in health economics from 2025 across policy, prevention, and health technology assessments (HTA) and shared predictions and themes that will define…
HTAi Asia Policy Forum Briefing Papers: Value and Affordability, Transferability, and Delivery of High Quality HTA for Decision Making
2 May 2017
The fourth annual meeting of the HTAi Asia Policy Forum was held in November 2016. OHE produced Background Briefing Papers for each of these four meetings covering a variety of…
Promoting Evidence-based Health Care Policy in Spain: EvaluAES 7th Annual Workshop
10 May 2018
…policies and health care services. There is a growing need to improve the efficiency and sustainability of health care systems everywhere. Evaluating health care policy and practice can be…